News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sharp Shalini
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Sharp Shalini (Director) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 4,290 options to buy
@ $95.27, valued at
$408.7k
Granted 2,100 restricted stock units
@ $0 |
|
| 01/24/2023 |
4
| Sharp Shalini (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 4,444 shares
@ $0
Granted 7,520 options to buy
@ $45.66, valued at
$343.4k
|
|
| 06/14/2022 |
4
| Sharp Shalini (Director) has filed a Form 4 on Organon & Co.|
Txns:
| Granted 5,640 options to buy
@ $35.46, valued at
$200k
|
|
| 06/08/2022 |
4
| Sharp Shalini (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.|
Txns:
| Granted 18,500 options to buy
@ $4.44, valued at
$82.1k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2022 |
4
| Sharp Shalini (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 2,546 shares
@ $0
Granted 3,688 options to buy
@ $124.31, valued at
$458.5k
|
|
| 06/08/2021 |
4
| Sharp Shalini (Director) has filed a Form 4 on Organon & Co.|
Txns:
| Granted 9,061 options to buy
@ $36.05, valued at
$326.6k
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/12/2021 |
4
| Sharp Shalini (Director) has filed a Form 4 on PRECISION BIOSCIENCES INC|
Txns:
| Granted 32,800 options to buy
@ $8.07, valued at
$264.7k
|
|
| 03/30/2021 |
4
| Sharp Shalini (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 2,424 shares
@ $0
Granted 3,523 options to buy
@ $164.98, valued at
$581.2k
|
|
| 03/30/2021 |
3
| Sharp Shalini (Director) has filed a Form 3 on Mirati Therapeutics, Inc. |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2020 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 461 shares
@ $88.24, valued at
$40.7k
Sold 2,560 shares
@ $88.54, valued at
$226.7k
Sold 500 shares
@ $88.38, valued at
$44.2k
Sold 7,188 shares
@ $88.38, valued at
$635.3k
Sold 3,669 shares
@ $88.38, valued at
$324.3k
Exercised 500 options to buy
@ $70.57, valued at
$35.3k
Exercised 7,188 options to buy
@ $67.55, valued at
$485.5k
Exercised 3,669 options to buy
@ $48.43, valued at
$177.7k
|
|
| 06/30/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/08/2020 |
4
| Sharp Shalini (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.|
Txns:
| Granted 12,000 options to buy
@ $9.83, valued at
$118k
|
|
| 06/05/2020 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 10,234 shares
@ $74.23, valued at
$759.7k
Sold 2,564 shares
@ $74.01, valued at
$189.8k
Exercised 10,234 options to buy
@ $48.43, valued at
$495.6k
Exercised 2,564 options to buy
@ $48.43, valued at
$124.2k
|
|
| 06/03/2020 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 348 shares
@ $69.38, valued at
$24.1k
|
|
| 05/20/2020 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 19,593 shares
@ $73.34, valued at
$1.4M
Sold 2,392 shares
@ $73.29, valued at
$175.3k
Sold 3,221 shares
@ $73.32, valued at
$236.2k
Sold 3,907 shares
@ $73.32, valued at
$286.5k
Exercised 19,593 options to buy
@ $70.57, valued at
$1.4M
Exercised 3,221 options to buy
@ $48.43, valued at
$156k
Exercised 3,907 options to buy
@ $70.57, valued at
$275.7k
|
|
| 05/15/2020 |
4
| Sharp Shalini (Director) has filed a Form 4 on PRECISION BIOSCIENCES INC|
Txns:
| Granted 41,038 options to buy
@ $6.62, valued at
$271.7k
|
|
| 05/08/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2020 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 248 shares
@ $58.57, valued at
$14.5k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/16/2019 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,434 shares
@ $0 |
|
| 09/17/2019 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Exercised 6,963 options to buy
@ $0.81, valued at
$5.6k
Exercised 24,880 options to buy
@ $6.86, valued at
$170.7k
|
|
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
4
| Sharp Shalini (Director) has filed a Form 4 on SUTRO BIOPHARMA, INC.|
Txns:
| Granted 11,610 options to buy
@ $11.12, valued at
$129.1k
|
|
| 06/04/2019 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 346 shares
@ $54.93, valued at
$19k
|
|
| 05/22/2019 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 381 shares
@ $59.5, valued at
$22.7k
|
|
| 05/07/2019 |
4
| Sharp Shalini (CFO & Executive Vice President) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 1,434 shares
@ $0 |
|
|
|
|